- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05029986
Preventing Dyspnea During Speech in Older Speakers
Self-Regulated Airflow Management in Daily Communicative Activities to Prevent Dyspnea During Speech in Older Speakers
Due to various comorbidities affecting the respiratory system, older speakers are at risk of experiencing breathing discomfort (dyspnea) during high-demand vocal activities such as singing, loud speaking, and speaking while exercising. Dyspnea during speech can promote avoidance of certain situations involving voice production, thus leading to vocal deconditioning and decreased quality of life. The goal of this pilot study is to test the feasibility and acceptability of a 4-week remote group intervention targeting phonatory dyspnea, and to gather preliminary efficacy data.
Participants will receive an intervention including a 2-week socialization phase (control condition) and a 4-week speech breathing intervention phase (experimental condition). Both phases will be delivered remotely and in a group setting (10 participants per group).
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Delaware
-
Newark, Delaware, Stati Uniti, 19713
- University of Delaware
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- sign the informed consent form
- report dyspnea in at least one of the items of the University of Cincinnati Dyspnea Questionnaire referring to speech
- be available during the dates of the scheduled group interventions
- be aged 50 years or older
Exclusion Criteria:
- do not have access to a computer and internet connection
- present with a known voice pathology (other than age-related vocal fold atrophy) and/or are receiving speech therapy at the time of the study
- have a known neurodegenerative disease affecting speech/voice
- are a current smoker
- are receiving pulmonary rehabilitation at the time of the study or are starting a new medication regimen for a respiratory disease at the time of study onset;
- have a hearing loss that is not adequately managed, as judged by the Principal Investigator (PI)
- have professional vocal training [amateur choir singers will not be excluded]
- cannot provide informed consent or easily follow instructions
- have any other condition that precludes them from participating in the behavioral interventions, as judged by the PI.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: All participants
This is a single-arm trial.
All participants will receive (1) a control condition (socialization phase, 2 weeks) and (2) an intervention condition (speech breathing intervention, 4 weeks).
Group sessions will take place once a week, and participants will be instructed to practice their exercises every day at home during the study duration.
|
Control condition: does not involve speech-related exercises
Experimental condition: involves speech-related exercises
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Change in reported dyspnea
Lasso di tempo: Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Participant self-ratings of dyspnea on the University of Cincinnati Dyspnea Questionnaire.
This questionnaire contains 30 items scored on a Likert scale ranging from 1 (not at all short of breath) to 5 (always short of breath or cannot do).
A higher scores indicates greater shortness of breath and therefore greater handicap.
|
Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Change in reported voice handicap
Lasso di tempo: Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Participant self-ratings of voice handicap on the Voice Handicap Index-10.
The Voice Handicap Index-10 is an ordinal scale that measures the degree of handicap a person experiences because of their voice disorder.
Each item is scored on a Likert scale ranging from 0 to 4. The minimum score is 0 and the maximal score 40.
A higher score indicates a greater perceived voice handicap.
|
Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Change in reported self-efficacy
Lasso di tempo: Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Participant self-ratings of self-efficacy for managing their symptoms, using the Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy Questionnaire - Managing Symptoms.
This questionnaire contains 28 items, each scored on a Likert scale ranging from 1 (I am not at all confident) to 5 (I am very confident).
A higher score indicates a greater self-efficacy.
|
Assessed at baseline, after the 2-week control condition, and after the 4-week experimental condition.
|
Acceptability of the intervention
Lasso di tempo: Assessed after the 4-week experimental condition, at the end of the study period.
|
Participants' perceived acceptability of the intervention using the Acceptability of Intervention Measure.
This questionnaire contains 5 items scored on a Likert scale ranging from 1 (completely disagree) to 5 (completely agree).
A higher score indicates a greater acceptability.
|
Assessed after the 4-week experimental condition, at the end of the study period.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 1767412
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Socialization phase
-
Guy's and St Thomas' NHS Foundation TrustB&D ElectromedicalCompletatoEccessivo collasso dinamico delle vie aeree | TracheobroncomalaciaRegno Unito
-
University Hospital, AntwerpCompletato
-
Boston University Charles River CampusNational Institute on Drug Abuse (NIDA)RitiratoSmettere di fumare